Back to News
Market Impact: 0.3

DA Davidson reiterates Riskified stock Buy rating on solid results By Investing.com

RSKD
Corporate EarningsAnalyst InsightsAnalyst EstimatesCompany FundamentalsCorporate Guidance & Outlook
DA Davidson reiterates Riskified stock Buy rating on solid results By Investing.com

DA Davidson reiterated a Buy rating on Riskified with a $6.00 price target, citing quarterly results that beat consensus on both revenue and earnings and strong new business wins/upselling. The company reported $345 million in trailing twelve-month revenue, a 52% gross margin, and a current ratio of 5.03, while the analyst raised 2026 and 2027 estimates. Separately, first-quarter 2026 revenue came in at $88.27 million versus $87.9 million expected, though EPS missed at -$0.03 versus $0.04 consensus.

Analysis

This reads less like a clean “beat” and more like evidence that the company is finally reaching the operating leverage inflection point. The market should focus on the mix: new logos plus expansion within existing accounts tends to be more durable than one-off pricing actions, and it usually translates into lower CAC payback and better retention over the next 2-4 quarters. If that pattern holds, the real upside is not the current quarter but the step-up in 2026/2027 free cash flow as gross profit scales faster than opex. The second-order winner is the broader trust-and-fraud software category: improving demand here is often a signal that merchants are willing to pay for conversion protection even in a tighter e-commerce environment. That can pressure adjacent point solutions that rely on discretionary spend, especially if buyers consolidate vendors around platforms with multi-product attachment. The risk for competitors is that budget holders start treating fraud prevention as a revenue-protection tool rather than a cost center, which increases the probability of share gains for the stronger product suites. The main bear case is that this still sits in a valuation regime where multiple expansion can outrun fundamentals, making the stock vulnerable if conversion of pipeline into billings slows for even one quarter. Because the balance sheet is healthy, downside is less about solvency and more about expectation reset: the stock could re-rate sharply if upsell velocity normalizes or if gross margin expansion stalls before cash flow inflects. In that scenario, the market likely punishes the stock over a 1-2 quarter horizon, not immediately. Consensus may be underestimating how much of the move is driven by estimate revisions rather than sentiment. When Street models move up, the stock can grind higher for months even without headline beats, but that also means the next leg requires evidence that the new guidance path is conservative. The contrarian setup is that if the implied FCF target is only mid-teens multiple and execution remains steady, the stock is still not expensive relative to other “prove-it” software names with weaker balance sheets and slower product adoption.